Startups have evolved into a significant aspect of the global economy, with a reported $7.6 trillion in value generated between 2021 and 2023. Despite the economy experiencing challenges, U.S. startups increased by 16 percent from 2019 to 2023. However, the failure rate is high, with over two-thirds of startups failing to yield positive returns for investors. A recent startup, Herasight, founded by geneticists, is positioned within the IVF sector and offers predictions on potential diseases in embryos, along with intelligence estimations based on specific criteria.
Over the past few months, we've been graced with such inspiring ventures as a Rent-A-Thug app, a for-profit alarm clock, and even an AI-powered camera that analyzes turds.
Herasight was unveiled by geneticists Tobias Wolfram and Alex Strudwick Young, who recently announced the company was coming out of 'stealth mode,' a period of secret development startups can use to protect intellectual property.
Young billed the company as an 'in-vitro fertilization (IVF) startup,' claiming it could predict the likelihood of 17 various diseases developing in a given set of embryos.
To use the widget to predict IQ, users first pick 'intelligence' from a list of traits and diseases including schizophrenia, melanoma, and gout.
Collection
[
|
...
]